Category: Makary, Marty

Trump to Nominate Heidi Overton, a Top Domestic Policy Aide, for F.D.A. Commissioner

The New York Times – Business:
Dr. Overton is a fierce opponent of abortion rights and a supporter of Health Secretary Robert F. Kennedy Jr.’s Make America Healthy Again agenda.
Rich Danker, RFK Jr.’s Top Spokesman, Resigns in Protest Over New Vaping Policy

The New York Times – Business:
In a letter to President Trump, the spokesman, Rich Danker, said allowing the sale of flavored e-cigarettes would enhance their appeal to children.
With a Friend in Trump, the Tobacco Industry Secures a Lucrative Win

The New York Times – Business:
In a dispute over vapes, the president sided with tobacco companies that filled his groups’ coffers over his own F.D.A. commissioner, who resigned in protest.
With a Friend in Trump, the Tobacco Industry Secures a Lucrative Win

The New York Times – Business:
In a dispute over vapes, the president sided with tobacco companies that filled his groups’ coffers over his own F.D.A. commissioner, who resigned in protest.
F.D.A. Commissioner Marty Makary Resigns After Weeks of Pressure

The New York Times – Business:
The agency’s top food official will step in as acting commissioner, after Dr. Makary’s tumultuous run as the nation’s top food, drug, tobacco and medical device regulator.
Trump Plans to Fire F.D.A. Commissioner Marty Makary

The New York Times – Business:
Dr. Makary has been a supporter of the Make American Healthy Again Movement but made some enemies in the administration over vaping, the abortion pill and rejections of new drugs.
F.D.A. Opens Door to More Flavored E-Cigarettes

The New York Times – Business:
The agency is proposing allowing other tastes for vapes, like mint, coffees, spices or tea, to appeal to adults. At the same time, illicit candy-flavored types aimed at teenagers have flooded the market.
U.S. Health Officials Defend Rejection of Moderna’s Flu Vaccine

The New York Times – Business:
The F.D.A.’s refusal to examine the company’s mRNA shot drew widespread criticism from doctors and was divisive within the agency.
F.D.A. Turmoil Keeps Spotlight on Its Commissioner

The agency’s high-level turnover and conflicting policy decisions on drug oversight have fueled concerns about the leadership of Dr. Marty Makary.
Kennedy’s Ties to Ally Leading Vaccine Lawsuits Raise Ethical Concerns

Aaron Siri is leading legal efforts on policies that dovetail with parts of Health Secretary Robert F. Kennedy Jr.’s government agenda.
F.D.A.’s Approval of Drug for Autism Upends Review Process

The agency revived an old treatment for cancer patients, unilaterally approving it for a subset of people with autism. Experts worry that the narrower scope will get lost in the hype.
F.D.A. Reviews Cases of Covid Vaccine Deaths

The agency plans to present accounts of deaths involving children and birth defects to an influential C.D.C. panel meeting next week.